STANDARD BIOTOOLS INC. — Director's Dealing 2024

Jun 27, 2024

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2024-06-18

Reporting Person: Casdin Amplify Fund, LP (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	545000	Indirect

Footnotes

F1: The securities are owned directly by Casdin Amplify Fund, LP ("Amplify") and may be deemed to be indirectly beneficially owned by (i) Casdin Capital, LLC, the investment adviser to Amplify ("Casdin"), (ii) Casdin Partners GP, LLC, the general partner of Amplify (the "GP"), and (iii) Eli Casdin, the managing member of Casdin and the GP.